These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 734225)

  • 1. Carbon-13 nuclear magnetic resonance identification of 2-hydroxy-3-O-methyl-6beta-naltrexol as a minor naltrexone metabolite.
    Brine GA; Brine DR; Welch CD; Bondeson VC; Carroll FI
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):455-64. PubMed ID: 734225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.
    Malspeis L; Bathala MS; Ludden TM; Bhat HB; Frank SG; Sokoloski TD; Morrison BE; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and disposition of naltrexone in man after oral and intravenous administration.
    Wall ME; Brine DR; Perez-Reyes M
    Drug Metab Dispos; 1981; 9(4):369-75. PubMed ID: 6114837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism of naltrexone in man.
    Wall ME; Brine DR; Perez-Reyes M
    NIDA Res Monogr; 1981; 28():105-31. PubMed ID: 6790999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone.
    Porter SJ; Somogyi AA; White JM
    Addict Biol; 2002 Apr; 7(2):219-25. PubMed ID: 12006217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol plasma levels in schizophrenic patients after large oral doses of naltrexone.
    Verebey K; Mulé SJ
    NIDA Res Monogr; 1979; 27():296-301. PubMed ID: 121346
    [No Abstract]   [Full Text] [Related]  

  • 8. Ring C conformation of 6beta-naltrexol and 6alpha-naltrexol. Evidence from proton and carbon-13 nuclear magnetic resonance.
    Brine GA; Praskash D; Hart CK; Kotchmar DJ; Moreland CG; Carroll FI
    J Org Chem; 1976 Oct; 41(21):3445-8. PubMed ID: 978296
    [No Abstract]   [Full Text] [Related]  

  • 9. Analytical methods for quantitative and qualitative analysis of naltrexone and metabolites in biological fluids.
    Wall ME; Brine DR
    NIDA Res Monogr; 1981; 28():52-65. PubMed ID: 6791013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and identification of a new metabolite of naltrexone in human blood and urine.
    Verebely K; Chedekel MA; Mule SJ; Rosenthal D
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):67-84. PubMed ID: 1188187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reduction of naltrexone II. In vitro studies using liver from guinea pig, monkey and rat.
    Malspeis L; Ludden TM; Bathala MS; Morrison BE; Feller DR; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):393-406. PubMed ID: 822483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification and measurement of two new metabolites of naltrexone in human urine.
    Cone EJ; Gorodetzky CW; Darwin WD; Carroll FI; Brine GA; Welch CD
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):413-33. PubMed ID: 674824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative determination of naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN) in human plasma, red blood cells, saliva and urine by gas liquid chromatography.
    Verebey K
    NIDA Res Monogr; 1981; 28():36-51. PubMed ID: 6791012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
    Meyer MC; Straughn AB; Lo MW; Schary WL; Whitney CC
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):15-9. PubMed ID: 6469932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stimulatory effect of morphine on reduction of naltrexone to 6 alpha-naltrexol in the guinea pig.
    Roerig SC; Fujimoto JM; Wang RI
    Drug Metab Dispos; 1980; 8(5):295-9. PubMed ID: 6107224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An electron-capture gas chromatographic assay for naltrexone in biological fluids.
    Reuning RH; Ashcraft SB; Morrison BE
    NIDA Res Monogr; 1981; 28():25-35. PubMed ID: 6791008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary characterization of enzymes for reduction of naloxone and naltrexone in rabbit and chicken liver.
    Roerig S; Fujimoto JM; Wang RI; Pollock SH; Lange D
    Drug Metab Dispos; 1976; 4(1):53-8. PubMed ID: 56258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6beta-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice.
    Yancey-Wrona JE; Raymond TJ; Mercer HK; Sadée W; Bilsky EJ
    Life Sci; 2009 Sep; 85(11-12):413-20. PubMed ID: 19583969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and inhibition of the formation of 6beta-naltrexol from naltrexone in human liver cytosol.
    Porter SJ; Somogyi AA; White JM
    Br J Clin Pharmacol; 2000 Nov; 50(5):465-71. PubMed ID: 11069441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.
    Taylor SM; Rodgers RM; Lynn RK; Gerber N
    J Pharmacol Exp Ther; 1980 May; 213(2):289-99. PubMed ID: 7365688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.